Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 29, 2011, Pages 12072-12077

  Kurokaw, Jun ^a   Nagano, Hiromichi ^a   Ohara, Osamu ^b   Kubota, Naoto ^c   Kadowaki, Takashi ^c   Arai, Satoko ^a   Miyazaki, Toru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KAZUSA DNA RESEARCH INSTITUTE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

CD36; Diabetes; Fatty acid synthase; Knockout mouse

Indexed keywords

APOPTOSIS INHIBITOR; APOPTOSIS INHIBITOR OF MACROPHAGE PROTEIN; CHEMOKINE; MESSENGER RNA; PALMITIC ACID; STEARIC ACID; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL MIGRATION; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOKINE PRODUCTION; FATTY ACID TRANSPORT; GLUCOSE INTOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY INFILTRATE; INSULIN RESISTANCE; LIPID DIET; LIPOLYSIS; MACROPHAGE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; WILD TYPE;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CHEMOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INSULIN RESISTANCE; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; OLIGONUCLEOTIDES; POLYMERASE CHAIN REACTION; RECEPTORS, IMMUNOLOGIC; RNA, SMALL INTERFERING; STATISTICS, NONPARAMETRIC; TOLL-LIKE RECEPTOR 4;

MUS;

EID: 79961038025     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1101841108     Document Type: Article

References (36)

1. Hotamisligil GS, Shargill N-S, Spiegelman B-M (1993) Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259:87-91. (Pubitemid 23036092)
2. Wellen KE, Hotamisligil GS (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112:1785-1788. (Pubitemid 38063699)
3. Arkan MC, et al. (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11:191-198. (Pubitemid 40321355)
4. Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116:1793-1801. (Pubitemid 44033299)
5. Weisberg SP, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808. (Pubitemid 38063703)
6. Xu H, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830. (Pubitemid 38063705)
7. Solinas G, et al. (2007) JNK1 in hematopoietically derived cells contributes to dietinduced inflammation and insulin resistance without affecting obesity. Cell Metab 6:386-397. (Pubitemid 350012000)
8. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953-964. (Pubitemid 41746764)
9. Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175-184. (Pubitemid 46048464)
10. Ozcan U, et al. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306:457-461. (Pubitemid 39372439)
11. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846. (Pubitemid 46024990)
12. Kosteli A, et al. (2010) Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest 120:3466-3479.
13. Miyazaki T, Hirokami Y, Matsuhashi N, Takatsuka H, Naito M (1999) Increased susceptibility of thymocytes to apoptosis in mice lacking AIM, a novel murine macrophagederived soluble factor belonging to the scavenger receptor cysteine-rich domain superfamily. J Exp Med 189:413-422. (Pubitemid 29063262)
14. Kurokawa J, et al. (2010) Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. Cell Metab 11:479-492.
15. Joseph SB, et al. (2004) LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119:299-309. (Pubitemid 39360910)
16. Valledor AF, et al. (2004) Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc Natl Acad Sci USA 101:17813-17818. (Pubitemid 40051969)
17. Gebe JA, et al. (1997) Molecular cloning, mapping to human chromosome 1 q21-q23, and cell binding characteristics of Spalpha, a new member of the scavenger receptor cysteine-rich (SRCR) family of proteins. J Biol Chem 272:6151-6158. (Pubitemid 27118082)
18. Kim WK, et al. (2008) Glycoproteomic analysis of plasma from patients with atopic dermatitis: CD5L and ApoE as potential biomarkers. Exp Mol Med 40:677-685.
19. Gray J, et al. (2009) A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease. BMC Cancer 9:271.
20. Arai S, et al. (2005) A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab 1:201-213. (Pubitemid 43960602)
21. Shi H, et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025. (Pubitemid 44684486)
22. Suganami T, et al. (2007) Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27:84-91. (Pubitemid 46370478)
23. Poggi M, et al. (2007) C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50:1267-1276. (Pubitemid 46701560)
24. Tsukumo DM, et al. (2007) Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56:1986-1998. (Pubitemid 47195825)
25. Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME (2008) Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 16:1248-1255. (Pubitemid 351770507)
26. Kamei N, et al. (2006) Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281:26602-26614. (Pubitemid 44401869)
27. Kanda H, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116:1494-1505.
28. Keophiphath M, Rouault C, Divoux A, Clément K, Lacasa D (2010) CCL5 promotes macrophage recruitment and survival in human adipose tissue. Arterioscler Thromb Vasc Biol 30:39-45.
29. Soma MR, Mims MP, Chari MV, Rees D, Morrisett JD (1992) Triglyceride metabolism in 3T3-L1 cells. An in vivo 13C NMR study. J Biol Chem 267:11168-11175.
30. Kopp A, et al. (2009) Fatty acids as metabolic mediators in innate immunity. Eur J Clin Invest 39:924-933.
31. Schaeffler A, et al. (2009) Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 126:233-245.
32. Jenkins KA, Mansell A (2010) TIR-containing adaptors in Toll-like receptor signalling. Cytokine 49:237-244.
33. Zechner R, Strauss JG, Haemmerle G, Lass A, Zimmermann R (2005) Lipolysis: Pathway under construction. Curr Opin Lipidol 16:333-340. (Pubitemid 40839763)
34. Nishino N, et al. (2008) FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J Clin Invest 118:2693-2696.
35. Schäffler A, Schölmerich J, Salzberger B (2007) Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol 28:393-399. (Pubitemid 47385374)
36. Hoshino K, et al. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J Immunol 162:3749-3752. (Pubitemid 29314747)